111 related articles for article (PubMed ID: 10346875)
1. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.
Decristoforo C; Mather SJ
Bioconjug Chem; 1999; 10(3):431-8. PubMed ID: 10346875
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
[TBL] [Abstract][Full Text] [Related]
3. Pyridine-containing 6-hydrazinonicotinamide derivatives as potential bifunctional chelators for 99mTc-labeling of small biomolecules.
Purohit A; Liu S; Ellars CE; Casebier D; Haber SB; Edwards DS
Bioconjug Chem; 2004; 15(4):728-37. PubMed ID: 15264859
[TBL] [Abstract][Full Text] [Related]
4. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands.
Liu S; Edwards DS; Harris AR
Bioconjug Chem; 1998; 9(5):583-95. PubMed ID: 9736492
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.
Decristoforo C; Mather SJ
Eur J Nucl Med; 1999 Aug; 26(8):869-76. PubMed ID: 10436200
[TBL] [Abstract][Full Text] [Related]
6. N,N-bis(2-mercaptoethyl)methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides.
Banerjee SR; Maresca KP; Stephenson KA; Valliant JF; Babich JW; Graham WA; Barzana M; Dong Q; Fischman AJ; Zubieta J
Bioconjug Chem; 2005; 16(4):885-902. PubMed ID: 16029030
[TBL] [Abstract][Full Text] [Related]
7. Technetium-binding in labelled HYNIC-peptide conjugates: role of coordinating amino acids.
Surfraz MB; King R; Mather SJ; Biagini S; Blower PJ
J Inorg Biochem; 2009 Jul; 103(7):971-7. PubMed ID: 19447500
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand.
Wang J; Kim YS; Liu S
Bioconjug Chem; 2008 Mar; 19(3):634-42. PubMed ID: 18281926
[TBL] [Abstract][Full Text] [Related]
10. Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with 99mTc using aminocarboxylates as coligands.
Liu S; Edwards DS; Looby RJ; Harris AR; Poirier MJ; Barrett JA; Heminway SJ; Carroll TR
Bioconjug Chem; 1996; 7(1):63-71. PubMed ID: 8741992
[TBL] [Abstract][Full Text] [Related]
11. Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.
Yu F; Lü ML; Zhang XP; Fu D; Hou M; Cai HD; Li D; Wang J; Yuan XY; Lü ZW; Dong F
Chin Med J (Engl); 2012 Jul; 125(14):2538-42. PubMed ID: 22882936
[TBL] [Abstract][Full Text] [Related]
12. Intracellular metabolic fate of radioactivity after injection of technetium-99m-labeled hydrazino nicotinamide derivatized proteins.
Ono M; Arano Y; Uehara T; Fujioka Y; Ogawa K; Namba S; Mukai T; Nakayama M; Saji H
Bioconjug Chem; 1999; 10(3):386-94. PubMed ID: 10346868
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of hydrazone formation in HYNIC-peptide conjugate preparation, and its hydrolysis during labeling with (99m)Tc.
Gandomkar M; Najafi R; Shafiei M; Ebrahimi SE
Appl Radiat Isot; 2007 Jul; 65(7):805-8. PubMed ID: 17467277
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of analogues of HYNIC as bifunctional chelators for technetium.
Meszaros LK; Dose A; Biagini SC; Blower PJ
Dalton Trans; 2011 Jun; 40(23):6260-7. PubMed ID: 21350776
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.
Broekema M; van Eerd JJ; Oyen WJ; Corstens FH; Liskamp RM; Boerman OC; Harris TD
J Med Chem; 2005 Oct; 48(20):6442-53. PubMed ID: 16190770
[TBL] [Abstract][Full Text] [Related]
16. Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imaging.
Erfani M; Shafiei M; Mazidi M; Goudarzi M
Cancer Biother Radiopharm; 2013 Apr; 28(3):240-7. PubMed ID: 23464855
[TBL] [Abstract][Full Text] [Related]
17. 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.
Decristoforo C; Melendez-Alafort L; Sosabowski JK; Mather SJ
J Nucl Med; 2000 Jun; 41(6):1114-9. PubMed ID: 10855644
[TBL] [Abstract][Full Text] [Related]
18. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
[TBL] [Abstract][Full Text] [Related]
19. Preclinical evaluation of [99mTc/EDDA/tricine/HYNIC0, 1-Nal3, Thr8]-octreotide as a new analogue in the detection of somatostatin-receptor-positive tumors.
Gandomkar M; Najafi R; Shafiei M; Mazidi M; Ebrahimi SE
Nucl Med Biol; 2007 Aug; 34(6):651-7. PubMed ID: 17707805
[TBL] [Abstract][Full Text] [Related]
20. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]